Farberg, Aaron S.
Portela, Dustin
Sharma, Divya
Kheterpal, Meenal
Funding for this research was provided by:
Sun Pharma
Article History
Accepted: 12 May 2024
First Online: 19 June 2024
Declarations
:
: Writing and editorial support for this manuscript, as well as the journal’s open-access fee, were funded by Sun Pharma.
: A.S.F is an advisor to Boehringer Ingelheim, Bristol Myers Squibb, Castle Biosciences, Galderma, InCyte, Janssen, L’Oréal, Novartis, Ortho Dermatologics, Pfizer, Regeneron Pharmaceuticals, Sanofi, and Sun Pharma. D.P. and D.S. do not have any conflicts of interest to disclose. M.K. received honoraria for advisory boards from LEO Pharma, Regeneron Pharmaceuticals, and Sun Pharma.
: Data sharing is not applicable to this article, as no data sets were generated or analyzed during the current study.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the interpretation of literature for the work, reviewed the manuscript critically for important intellectual content, read and approved the final version for submission, and agree to be accountable for all aspects of the work.